FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/10/2026
Back to search
Official data from USPTO
SELNECITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/11/2026
Trademark type
Word
Nice classes
5
Filing date
05/06/2024
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
05/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
DE
Examiner
JANSON, ANDREW KYLE
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
MAX MOSKOWITZ OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparationscell based immune therapeutics for treatment of cancerfor treatment of immunological diseasestreatment of infectious diseases; excluding pharmaceutical preparations to treat hormonal diseases and disordersendocrine diseases and disorders and congenital adrenal hyperplasia
Publications
History of USPTO decisions and trademark events.
25 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/15/2026
OP.T
OPPOSITION TERMINATED NO. 999999
01/15/2026
OP.D
OPPOSITION DISMISSED NO. 999999
01/15/2026
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/01/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/24/2025
RFNP
REFUSAL PROCESSED BY IB
07/05/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/18/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
06/18/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
06/16/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
06/15/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/17/2024
NPUB
NOTICE OF PUBLICATION
12/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2024
DOCK
ASSIGNED TO EXAMINER
11/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/23/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2024
Continuous trademark protection
Get notified about every new filing that threatens SELNECITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.